Mdluli and co corruption trial postponed

This is to allow the former crime intelligence boss to get a response on his state funding application.

2021-06-18 12:11:00 PM

JUST IN: The court was meant to hear if Richard Mdluli had managed to get state legal support after the high court gave him a month to apply for funding.

This is to allow the former crime intelligence boss to get a response on his state funding application.

Read more: The Citizen News »

5 ways to help after the devastating looting in KZN

Communities in KwaZulu-Natal are desperate for even the most basic food staples after a week of devastating looting and violence. In honour of Mandela Day, and in the spirit of Ubuntu, here are five ways you can help out.

SLUSH FUNDS

More transparency is a crucial ingredient to fight corruption in the construction sectorRegular reporting of contract documentation will boost a new initiative to detect and prevent corruption

Mercedes postpone Grosjean's F1 farewell testMercedes have postponed a test with French driver Romain Grosjean due to travel restrictions and quarantine requirements, the Formula One world champions said on Wednesday

Shocked by Covid-19 deaths, young Indians rush for life insuranceLike many other twenty-somethings in India, Beverly Coutinho kept postponing buying a life insurance policy, until a surge in Covid-19 cases and deaths made her confront her own mortality.

Court to hear whether state will pay Mdluli's legal costsMdluli wants the SAPS to pay for his legal fees because the criminal acts he is charged with happened while he was employed by the police. 🤣 🤣 🤣 🤣 Why did you commit crime mnr A little bit cheeky, I would would think. Police are supposed to catch criminals, not sponsor them...

PETER BRUCE: Trust SA to cock up even benign forms of corruptionA book on how some forms of graft work to grow the economy needs to be studied, especially by ANC's factions

Newsdeck: CureVac fails in pivotal COVID-19 vaccine trial with 47% efficacyJune 16 (Reuters) - German biotech CureVac NV said on Wednesday its COVID-19 vaccine was only 47% effective in a late-stage trial, missing the study's main goal and throwing in doubt the potential delivery of hundreds of millions of doses to the European Union.